Compare CRBG & OMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRBG | OMC |
|---|---|---|
| Founded | 1957 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Advertising |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 14.9B |
| IPO Year | 2022 | N/A |
| Metric | CRBG | OMC |
|---|---|---|
| Price | $30.44 | $74.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | $38.75 | ★ $97.14 |
| AVG Volume (30 Days) | ★ 6.7M | 5.0M |
| Earning Date | 11-03-2025 | 10-21-2025 |
| Dividend Yield | 3.16% | ★ 4.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.78 | ★ 6.79 |
| Revenue | ★ $18,335,000,000.00 | $16,065,300,000.00 |
| Revenue This Year | $5.41 | $4.68 |
| Revenue Next Year | $8.77 | $3.44 |
| P/E Ratio | $17.06 | ★ $10.82 |
| Revenue Growth | ★ 15.16 | 4.13 |
| 52 Week Low | $23.69 | $68.37 |
| 52 Week High | $36.57 | $104.22 |
| Indicator | CRBG | OMC |
|---|---|---|
| Relative Strength Index (RSI) | 53.54 | 50.17 |
| Support Level | $28.78 | $69.86 |
| Resistance Level | $30.30 | $73.04 |
| Average True Range (ATR) | 0.83 | 2.14 |
| MACD | 0.28 | 0.07 |
| Stochastic Oscillator | 87.46 | 63.34 |
Corebridge Financial Inc provides retirement solutions and insurance products in the United States. It offers a broad set of products and services through five segments Individual Retirement, Group Retirement, Life Insurance, Institutional Markets businesses, Corporate and Other. The majority of its revenue derives from the Individual Retirement segment.
Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, ad placement, and public relations. The firm operates globally, providing services in more than 70 countries; it generates more than one half of its revenue in North America and nearly 30% in Europe.